메뉴 건너뛰기
Archives of Neurology
Volumn 61, Issue 12, 2004, Pages 1972-1973
Initial Parkinson disease therapy: Levodopa, dopamine agonists, or both?
Author keywords

[No Author keywords available]
Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;
EID: 10044241817     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.12.1972     Document Type: Article
Times cited : (6)
References (9)
  • 1
    • 0022627693 scopus 로고
    • Initiation of levodopa therapy in Parkinsonian patients should be delayed until the advanced stages of the disease
    • Melamed E. Initiation of levodopa therapy in Parkinsonian patients should be delayed until the advanced stages of the disease. Arch Neurol. 1986; 43:402-405.
    • (1986) Arch Neurol , vol.43 , pp. 402-405
    • Melamed, E.1
  • 2
    • 0022652016 scopus 로고
    • Modification of Parkinson's disease by long-term levodopa treatment
    • Markham CH, Diamond SG. Modification of Parkinson's disease by long-term levodopa treatment. Arch Neurol. 1986;43:405-407.
    • (1986) Arch Neurol , vol.43 , pp. 405-407
    • Markham, C.H.1    Diamond, S.G.2
  • 3
    • 0022622817 scopus 로고
    • Timing of levodopa therapy
    • Hachinski V. Timing of levodopa therapy. Arch Neurol. 1986;43:407.
    • (1986) Arch Neurol , vol.43 , pp. 407
    • Hachinski, V.1
  • 4
    • 0347133331 scopus 로고    scopus 로고
    • Neuroprotection in Parkinson disease: Mysteries, myths, and misconceptions
    • Schapira AH, Olanow CW. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA. 2004;291:358-364.
    • (2004) JAMA , vol.291 , pp. 358-364
    • Schapira, A.H.1    Olanow, C.W.2
  • 5
    • 0037039267 scopus 로고    scopus 로고
    • Practice parameter, initiation of treatment for Parkinson's disease: An evidence based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology
    • Miyasaki JM, Martin W, Suchowersky O, et al. Practice parameter, initiation of treatment for Parkinson's disease: an evidence based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002;58:11-17.
    • (2002) Neurology , vol.58 , pp. 11-17
    • Miyasaki, J.M.1    Martin, W.2    Suchowersky, O.3
  • 6
    • 0037432067 scopus 로고    scopus 로고
    • Slowing Parkinson's disease progression: Recent dopamine agonist trials
    • Ahlskog JE. Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology, 2003;60:381-389.
    • (2003) Neurology , vol.60 , pp. 381-389
    • Ahlskog, J.E.1
  • 7
    • 0037432040 scopus 로고    scopus 로고
    • Initial agonist treatment of Parkinson disease: A critique
    • Albin RL, Frey KA. Initial agonist treatment of Parkinson disease: a critique. Neurology. 2003;60: 390-394.
    • (2003) Neurology , vol.60 , pp. 390-394
    • Albin, R.L.1    Frey, K.A.2
  • 8
    • 10044278205 scopus 로고    scopus 로고
    • Initial treatment of Parkinson disease: Levodopa or dopamine agonists
    • Weiner WJ. Initial treatment of Parkinson disease: levodopa or dopamine agonists. Arch Neurol. 2004; 61:1966-1969.
    • (2004) Arch Neurol , vol.61 , pp. 1966-1969
    • Weiner, W.J.1
  • 9
    • 10044237961 scopus 로고    scopus 로고
    • Dopamine agonists modify the course of Parkinson disease
    • Stern MB. Dopamine agonists modify the course of Parkinson disease. Arch Neurol. 2004;61:1969-1971.
    • (2004) Arch Neurol , vol.61 , pp. 1969-1971
    • Stern, M.B.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.